Zur Eyal
Super-Pharm, Petach-Tikvah, Israel.
Int J Pharm Compd. 2012 May-Jun;16(3):196-205.
Burning mouth syndrome is a complex pathology for which there is very little information about the etiology and pathogenesis. This lack of knowledge leaves patients with suboptimal treatments. This article discusses the existing scientific evidence about this disease. Since topical oral use of clonazepam have been shown to be effective and safe to treat some patients suffering with burning mouth syndrome, formulations including clonazepam are included with this article. Compounding topical preparations of clonazepam offers opportunities for compounding pharmacists to be more involved in improving the quality of life of burning mouth syndrome patients.
灼口综合征是一种复杂的病症,关于其病因和发病机制的信息非常少。这种知识的匮乏使得患者接受的治疗效果欠佳。本文讨论了关于这种疾病的现有科学证据。由于局部口腔使用氯硝西泮已被证明对治疗一些灼口综合征患者有效且安全,因此本文包含了含有氯硝西泮的制剂。配制氯硝西泮局部制剂为配制药剂师更深入参与改善灼口综合征患者的生活质量提供了机会。